My watch list  


Systematic (IUPAC) name
2,2,2-trichloroethanol dihydrogen phosphate
CAS number 306-52-5
ATC code N05CM07
PubChem 5563
Chemical data
Formula C2H4Cl3O4P 
Mol. mass 229.383
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.


Legal status
Routes  ?

Triclofos is a sedative drug used rarely for treating insomnia, usually as a second-line treatment after other drugs have failed. Triclofos may cause dependance and should not be withdrawn suddenly. This drug should only be used for the short term relief of severe insomnia and should not be mixed with alcohol or other depressant drugs. Patients should not drive or use machinery after taking triclofos.

Triclofos is a prodrug which is metabolised in the liver into the active drug trichloroethanol. This delayed action means that the half-life of triclofos is fairly long and it may cause drowsiness the next day. Trichloroethanol may cause liver damage and triclofos should not be used for extended periods.

Side effects

Side effects may include: Headache, Rash, Dizziness, Flatulence, Confusion, Nightmares, Dependence, Diarrhoea, Constipation, Nausea, Vomiting, Abdominal pain, Ataxia

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Triclofos". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE